Get started
RocketTickers

US FDA approves Jardiance® (empagliflozin) to treat adults with

Long
Eli Lilly and Company (NYSE:LLY)  
RocketTickers  
NYSE:LLY   Eli Lilly and Company
Beyond Technical Analysis
0
0
beyondta
LLY: Eli Lilly and Company
2022-02-24 16:00:00
US FDA approves Jardiance® (empagliflozin) to treat adults with heart failure regardless of left ventricular ejection fraction
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.